Split History
ETFs Holding AMRN »    AMRN Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Amarin is a biopharmaceutical company, which focused on the commercialization and development of therapeutics for cardiovascular health. Co.'s main product, Vascepa® (icosapent ethyl) capsules, is for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. Co. refers this indication for Vascepa as the MARINE indication. Co. is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol, levels which condition Co. refer to as mixed dyslipidemia. Vascepa is available in the U.S. by prescription only. According to our AMRN split history records, Amarin has had 1 split.
AMRN split history picture
Amarin (AMRN) has 1 split in our AMRN split history database. The split for AMRN took place on October 19, 1998. This was a 1 for 10 reverse split, meaning for each 10 shares of AMRN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as Amarin conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the AMRN split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Amarin shares, starting with a $10,000 purchase of AMRN, presented on a split-history-adjusted basis factoring in the complete AMRN split history. AMRN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/20/2007
End date: 09/19/2017
Start price/share: $0.49
End price/share: $3.22
Dividends collected/share: $0.00
Total return: 557.14%
Average Annual Total Return: 20.70%
Starting investment: $10,000.00
Ending investment: $65,693.20
Years: 10.01
Date Ratio
10/19/19981 for 10
AMRN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

AMSG Split History
ANCI Split History
ANIP Split History
ANTH Split History
APEN Split History
APHB Split History
APPY Split History
APRI Split History
ARA Split History
ARNA Split History

Mer Telemanagement Solutions Ltd. (MTSL)
Merrimack Pharmaceuticals (MACK)
Diana Containerships Inc. (DCIX)
Farmers & Merchants Bancorp, Inc. (FMAO)
Henry Schein, Inc. (HSIC)
Intuitive Surgical, Inc. (ISRG)
Diana Containerships Inc. (DCIX)
Bridgeline Digital, Inc. (BLIN)
SUPERVALU INC. (SVU)
DryShips Inc. (DRYS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

AMRN Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.